Jun 10, 2016 11:03 AM IST
Rajat Bose of rajatkbose.com is of the view that Cipla may test Rs 491 while IPCA Labs may hit Rs 477.
- Jun 08, 2016 12:58 PM IST
IPCA has lost 50 percent of its market cap in the past year due to the US FDA issues at three facilities and its impact on other businesses. According to the brokerage firm, India business growth has remained resilient in the turmoil.
- Jun 08, 2016 09:39 AM IST
Rajat Bose of rajatkbose.com recommends buying ICICI Bank, State Bank of India and IPCA Laboratories.
- May 30, 2016 01:30 PM IST
Operating profit (EBITDA - earnings before interest, tax, depreciation and amortisation) shot up 72.2 percent to Rs 63.5 crore and margin expanded by 440 basis points to 10.2 percent in Q4.
- Apr 26, 2016 08:27 AM IST
CNBC-TV18's analysts gives stocks to keep on your radar for trade today - stocks expected to be under pressure today are ABB India, IPCA Labs, State Bank of Travancore, Sun Pharma, ITC, Godfrey Phillips and VST Industries while the stocks expected to gain are Indiabulls Housing, Bharti Airtel, Shilcar Tech, Novartis India and Excel Crop Care.
- Apr 12, 2016 04:58 PM IST
Edelweiss is bearish on Ipca Labs has recommended reduce rating on the stock with a target price of Rs 440 in its research report dated April 7, 2016.
- Apr 08, 2016 01:55 PM IST
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Tata Power, Ipca Labarotories, Reliance Infrastructure, BHEL, JSPL, Sagar Cement, Rajshree Sugar and Ricoh India.
- Apr 08, 2016 11:45 AM IST
Ashwani Gujral of ashwanigujral.com is of the view that one can buy India Cements and Havells India.
- Apr 08, 2016 09:53 AM IST
Ipca received warning letter from USFDA for its Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa) manufacturing units.
- Apr 08, 2016 09:13 AM IST
Surya Patra, pharma analyst at Phillip Capital now estimates IPCA's institutional revenues to fall to around Rs 200 crore, from its earlier estimate of around Rs 260 crore
- Apr 08, 2016 08:52 AM IST
In a regulatory filing, Ipca Laboratories said the Geneva-based organisation that provides financial aid against AIDS, tuberculosis and malaria, has informed the company about its decision on Wednesday via a letter.
- Apr 08, 2016 08:44 AM IST
Here are stocks likely to be in the limelight in today's trade
- Apr 08, 2016 08:17 AM IST
Cairn India | NMDC | Ipca Labs | Adani Enterprises | Sagar Cement | NBCC | IVRCL | PNC Infratech | Jyoti Structures | Simplex Projects and Reliance Communications are stocks, which are in the news today.
- Mar 23, 2016 02:44 PM IST
The valuation of the deal would be around Rs 250-300 crore, say sources, adding IPCA Labs had already invested in Gammon's transmission and distribution business.
- Mar 14, 2016 09:18 AM IST
Hailing the government's move, Surajit Pal, pharma analyst at Prabhudas Lilladher, says the aim of regulation is to prevent rampant use of antibiotics. He says Abbott is likely to be severely impacted by the move as it has around 15.4 percent exposure to fixed-dosed combinations.
- Mar 09, 2016 12:32 PM IST
According to Credit Suisse, slower ramp-up in malaria tender business in Africa, pricing policy hit in India portfolio starting April 2016 and potential nine-month delay in resolution in the US post the warning letter may have combined impact of 17 percent to FY17 earnings per share (EPS) and 11 percent to FY18 EPS.
- Feb 16, 2016 08:02 AM IST
According to the warning letter sent by the USFDA over the three plants, its inspectors observed systemic data manipulation and other current good manufacturing practices (CGMP) violations and deviations at the company's three facilities.
- Feb 10, 2016 02:08 PM IST
Motilal Oswal has recommended neutral rating on Ipca Labs with a target price of Rs 680 in its research report dated February 8, 2016.
- Feb 08, 2016 01:07 PM IST
Operating profit (earnings before interest, tax, depreciation and amortisation) in October-December period dropped 26 percent to Rs 89.25 crore and margin contracted by 331 basis points to 13.05 percent compared to corresponding quarter of last fiscal.
- Feb 01, 2016 12:35 PM IST
Ipca Labs already voluntarily suspended shipments of its APIs and formulations for the US market till USFDA inspection observations are resolved.
- Jan 05, 2016 03:33 PM IST
Mayuresh Joshi of Angel Broking is of the view that one may prefer Ipca Laboratories.
- Jan 01, 2016 03:05 PM IST
Amit Harchekar of A-Plus Analytics is of the view that one may pick Ipca Laboratories and Siemens.
- Dec 14, 2015 05:01 PM IST
Mayuresh Joshi of Angel Broking feels that Ipca Laboratories may test Rs 900.
- Dec 01, 2015 02:37 PM IST
Rahul Mohindar of viratechindia.com recommends buying Hindalco Industries, Marico and Ipca Labs.
- Nov 16, 2015 04:00 PM IST
Sun Pharma and Dr Reddy‘s are long-term winners, Anmol Ganjoo, Pharma analyst at JM Financial said adding that there is still scopr for further US FDA actions.